Merck moves tropical disease drug into phase II
June 25, 2010Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease
Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
Clavis Pharma appoints Athos Gianella-Borradori
June 24, 2010Research and Development Clavis Pharma, appointment, research and development
Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …
NICE rejects Glivec as adjuvant therapy
June 24, 2010Sales and Marketing Glivec, NICE, Novartis
NICE has rejected the use of Novartis’ Glivec as an adjuvant treatment for people who have had a gastrointestinal stromal …
AstraZeneca and Targacept begin depression trials
June 24, 2010Research and Development AstraZeneca, Targacept, depression
AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …
CME Spotlight: Coalition politics in European CME
June 24, 2010Medical Communications CME, CME Spotlight
The election is now over and rather than the damp squib that I foresaw, it feels like something new and …
Prix Galien shortlist unveiled
June 24, 2010Research and Development prix galien
The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …
Pfizer plant cleared by FDA to make NicOx drug
June 24, 2010Manufacturing and Production Capsugel, NicOx, Pfizer, manufacturing, naproxcinod
Pfizer subsidiary Capsugel has won approval from the US Food and Drug Administration for a manufacturing facility based in France …
Digital Pharma: Playing healthcare games
June 23, 2010Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games
Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …
Plans for UK’s research hub unveiled
June 23, 2010Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical
The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
Prosensa and GSK add to muscular dystrophy alliance
June 23, 2010Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy
GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …
Mixed reaction for Osborne’s first Budget
June 23, 2010Research and Development, Sales and Marketing biotech, pharma, tax, tax relief
George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
Congress summons J&J chief executive
June 23, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …
PRA bolsters late phase services
June 23, 2010Research and Development CRO, PRA, appointment, research and development
Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …
Sanofi signs microRNA therapy deal
June 23, 2010Research and Development RNA, Regulus, Sanofi-Aventis
Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …
Medical Affairs at the Centre of Life Sciences Innovation
June 22, 2010Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf
In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Europe must move on from ‘simplistic’ pricing
June 22, 2010Research and Development Europe, hta, pricing, pricing & Reimbursement
GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
Pfizer withdraws blood cancer drug in US
June 22, 2010Sales and Marketing AML, Mylotarg, Pfizer, blood cancer
The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …
NHS targets and management costs in the firing line
June 22, 2010NHS, NHS funding, NHS targets
Management costs and the use of targets are at the top of the government’s NHS hitlist, the health secretary Andrew Lansley has …
FDA tightens pharma’s responsibility for outsourcing
June 22, 2010Manufacturing and Production FDA, GMP, manufacturing, outsourcing
Pharmaceutical manufacturers will be held more responsible for the activities of their suppliers and outsourcing partners under a new approach …
Manufacturing news in brief
June 22, 2010Manufacturing and Production Almac, CPL Biologicals, KV Pharma, KV Pharmaceutical, NerPharMa, ProBioGen
German contract manufacturer ProBioGen is bought by Egypt’s Minapharm, plus there are facility updates from NerPharMa DS, CPL Biologicals and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
